Registered Attendees

Registered Attendees

Print This Page

Registered attendees (and speakers, organizers, etc.) will have access to the following items from their Account page:

  • Abstracts from speakers and poster sessions, including the joint meeting abstracts, available 30 days prior to the meeting (You can edit your own abstract from My Account page as well)

    NOTE: Abstract authors/submitters may choose to not have their abstract available online before the meeting...these abstracts will be available in the Abstract Book at the meeting.

  • Full participant list, including joint meeting participants
  • Printable Invoices and Invitation Letters
  • Scholarship Information
  • Lodging Information

Login to My Account page

Close Window
Clarion Hotel Sign Floorplan

Clarion Hotel Sign Floorplan

Print This Page



Close Window
NOTES:
This meeting will be conducted in English.

All programs are subject to change. Check this site for updates.

Download Flyer

Human Genomics and Personalized Medicine (E3)

Scientific Organizers: Kelly A. Frazer and Geoffrey S. Ginsburg


June 17—21, 2013

Clarion Hotel Sign, Stockholm, Sweden


Organized in collaboration with Knut and Alice Wallenberg Foundation and Science for Life Laboratory - Stockholm. Sponsored by AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Inc., H3 Biomedicine Inc., Nestlé Institute of Health Sciences and Onyx Pharmaceuticals, Inc.


Abstract submission is closed. Registered attendees can bring a poster onsite. Please contact our office at +1 800-253-0685; +1 970-262-1230 or email info@keystonesymposia.org if you are interested. DEADLINES:
Scholarship Deadline: Feb 20, 2013 [details]
Abstract Deadline: Feb 20, 2013 [details]
Late Abstract Deadline: Mar 19, 2013 [details]
Early Registration Deadline: Apr 16, 2013 [details]

Register Yourself Deadlines and Fees
Deadlines and Fees for 2013-E3 ''Human Genomics and Personalized Medicine''
Print This Page

Rates and Deadlines listed below are for the 2013-E3 "Human Genomics and Personalized Medicine" conference only.

*All deadlines end at 12:00 midnight US Mountain Standard Time

Deadline Date Cost
Abstract
More details		 Before and On February 20, 2013 50.00 USD*
Late Abstract
More details		 After February 20, 2013 until April 16, 2013 50.00 USD* (abstract fee)
+ 50.00 (late fee)
100.00 (total cost) USD
* 50.00 USD of Abstract fee deducted from your registration fee when you register for this meeting
Scholarship
More details		 February 20, 2013 n/a
Early NON-STUDENT Registration
More details		 Before and On April 16, 2013 795.00 USD
(includes 150.00 discount)
Regular NON-STUDENT Registration
More details		 After April 16, 2013 945.00 USD
Early STUDENT Registration
More details		 Before and On April 16, 2013 570.00 USD
(includes 150.00 discount)
Regular STUDENT Registration
More details		 After April 16, 2013 720.00 USD

* Changes in payment type that result in a refund are subject to a processing fee.
* Currency exchange gains/losses are the responsibility of the registrant and the Keystone Symposia will    accept no liability for money loss through bank charges, transfers or currency fluctuations.

Close Window



About Abstract Deadline
About Global Health Travel Award Deadline
About Scholarship Deadline
About Late Abstract Deadline
About Early Registration Deadline

Conference Program    Print  |   View meeting in 12 hr (am/pm) time


MONDAY, JUNE 17

12:00—20:00
Arrival and Registration

Foyer
15:30—16:00
Coffee & Snacks Available

Foyer
16:00—17:00
Welcome and Keynote Address
Registered attendees can view abstracts starting on 05/17/2013

B 1-2
* Geoffrey S. Ginsburg, Duke University, USA
Welcome Remarks

John Bell, University of Oxford, UK
Bringing Genomics to the Bedside

17:00—19:00
Breakthroughs in Genomic and Personalized Medicine
Registered attendees can view abstracts starting on 05/17/2013

B 1-2
* Kelly A. Frazer, University of California, San Diego, USA

Peter Mueller, Vertex Pharmaceuticals Incorporated, USA
Kalydeco: Targeting the G551D Mutation in CF

Geoffrey S. Ginsburg, Duke University, USA
Novel Host-Based Approaches to the Diagnosis of Infectious Disease

Stephen F. Kingsmore, Children’s Mercy Hospital, USA
Talk Title to be Determined


TUESDAY, JUNE 18

07:30—08:30
Breakfast

Individual Hotel
07:30—08:00
Poster Setup

B3
08:00—15:30
Poster Viewing

B3
08:30—11:30
Genomes and Biology
Registered attendees can view abstracts starting on 05/17/2013

B 1-2
* Thomas J. Hudson, Ontario Institute for Cancer Research, Canada

Mathias Uhlén, Royal Institute of Technology, Sweden
Defining the Human Tissue-Specific Proteome based on Transcriptomics and Antibody-Based Protein Profiling

Kelly A. Frazer, University of California, San Diego, USA
Genomic Approaches to Understanding Cancer Progression

Martin J. Blaser, New York University School of Medicine, USA
Perturbing the Early Life Microbiome and its Consequences

Andrew P. Feinberg, Johns Hopkins University School of Medicine, USA
The Epigenetic Basis of Common Human Disease

Lili Milani, University of Tartu, Estonia
Short Talk: Genome-Wide DNA Methylation and Gene Expression Changes in Whole Blood, CD4+ and CD8+ T-Cells during Healthy Aging

09:50—10:10
Coffee Break

Foyer/B3
11:30—12:30
Lunch

Foyer/B3
12:30—15:00
Poster Session 1

B3
15:00—15:30
Coffee Available

Foyer/B3
15:30—18:15
Cancer Genomics and Applications
Registered attendees can view abstracts starting on 05/17/2013

B 1-2
* Andrew P. Feinberg, Johns Hopkins University School of Medicine, USA

Paul S. Mischel, University of California, San Diego, USA
The Cancer Genome Atlas and the Future of Cancer Diagnosis and Treatment

Thomas J. Hudson, Ontario Institute for Cancer Research, Canada
Linking Cancer Treatment Decisions with Large-Scale Mutation Surveys

Jessica Nordlund, Uppsala University, Sweden
Short Talk: The DNA Methylation Landscape of Pediatric Acute Lymphoblastic Leukemia

Steven Shak, Genomic Health Inc., USA
Translating Genomics into Clinical Practice: Lessons from Oncotype DX

Hiroyuki Mano, University of Tokyo, Japan
Targeting Essential Growth Drivers in Human Cancer

18:15—00:00
On Own for Dinner


WEDNESDAY, JUNE 19

07:30—08:30
Breakfast

Individual Hotel
08:30—11:30
Advances and Challenges in the Field
Registered attendees can view abstracts starting on 05/17/2013

B 1-2
* Kelly A. Frazer, University of California, San Diego, USA

Janet Woodcock, US Food and Drug Administration, USA
A Regulatory Pathway to Personalized Medicine

Dan M. Roden, Vanderbilt University School of Medicine, USA
Integration and Implementation of Genetic Information into Health Systems

Jill P. Mesirov, Broad Institute, USA
Computational Approaches for Genomic Medicine

Howard J. Jacob, Medical College of Wisconsin, USA
Advances in Clinical Sequencing

X. Sunney Xie, Harvard University, USA
Short Talk: Single-Cell Genomics: Life at the Single Molecule Level

09:50—10:10
Coffee Break

Foyer/B3
11:30—13:00
Poster Setup

B3
11:30—12:30
Lunch

Foyer/B3
12:30—22:00
Poster Viewing

B3
12:30—15:00
Pharmacogenomics
Registered attendees can view abstracts starting on 05/17/2013

B 1-2
* Dan M. Roden, Vanderbilt University School of Medicine, USA

Alan R. Shuldiner, University of Maryland School of Medicine, USA
Genomic Management of Anti-Platelet Therapeutics

Y.T. Chen, Duke University, USA
Realizing the Promise of Personalized Medicine: HLA-B*1502 Screen in Preventing Carbamazepine-Induced Toxic Effects

Keith J. Johnson, Novartis Institutes for BioMedical Research, Inc., USA
Pharmacogenetic Applications to Enable Drug Development for General Medicine Indications

Federico Innocenti, University of North Carolina at Chapel Hill, USA
Pharmacogenetics of Cancer Therapeutics: Focus on the Germline Genome

Shannon Gibson, University of Toronto, Canada
Short Talk: Ethical, Legal and Social Issues in Pharmacogenomics: A Qualitative Study of the Perspectives of Canadian Stakeholders

15:00—15:30
Coffee Available

Foyer/B3
15:30—17:30
Personalized Genomes
Registered attendees can view abstracts starting on 05/17/2013

B 1-2
* Howard J. Jacob, Medical College of Wisconsin, USA

Michael Snyder, Stanford University School of Medicine, USA
Adventures in Personal Genomics: iPOP of Healthy and Disease States

William A. Gahl, NHGRI, National Institutes of Health, USA
Whole Exome Sequencing for Undiagnosed Diseases

Alan H. Bryce, Mayo Clinic, USA
Short Talk: A Pilot Study of Whole Genome, Whole Exome and RNA Sequencing with CLIA Validation to Identify Potential Therapeutic Targets in Advanced Cancer Patients

George M. Church, Harvard Medical School, USA
The Personal Genome Project and the Future of Medicine

17:30—18:30
Social Hour w/ Lite Bites

Foyer/B3
18:30—21:00
Poster Session 2

B3

THURSDAY, JUNE 20

07:30—08:30
Breakfast

Individual Hotel
08:30—11:30
Policy
Registered attendees can view abstracts starting on 05/17/2013

B 1-2
* Janet Woodcock, US Food and Drug Administration, USA

Susanne B. Haga, Duke University, USA
Introducing Genomics in the Clinic: Development of New Delivery Systems

Laura Lyman Rodriguez, NHGRI, National Institutes of Health, USA
Bringing Genomics into Medicine: Advancing the Policy Agenda

Andelka M. Phillips†, University of Oxford, UK
Short Talk: We Agree to Sequence your Genomic Data, and you Agree to X, Y, Z…

Katherine Payne, University of Manchester, UK
Quantifying the Economic Value of Personalized Medicine

Jane Kaye, University of Oxford, UK
Privacy, Data-Sharing Frameworks, Global Governance and Translational Research

09:50—10:10
Coffee Break

Foyer/B3
 
On Own for Lunch and Recreation

16:30—17:00
Coffee Available

Foyer/B3
17:00—19:00
Translating Biomarkers to Personalized Medicine
Registered attendees can view abstracts starting on 05/17/2013

B 1-2
* Geoffrey S. Ginsburg, Duke University, USA

Michelle Penny, Eli Lilly and Company, USA
Integration of Genomic Technologies into Drug Discovery and Development

Johan Lindberg, Karolinska Institutet, Sweden
Short Talk: Exome Sequencing of Cell-Free Plasma DNA in Prostate Cancer Patients

Johan Lundin, University of Helsinki, Finland
Developing Diagnostics from Biomarkers

Thomas Metcalfe, Oncotest GmbH - Institute for Experimental Oncology, Germany
Co-Development of Therapeutics and Companion Diagnostics

19:00—20:00
Social Hour w/ Lite Bites

B 2-3
20:00—23:00
Entertainment

B 2-3

FRIDAY, JUNE 21

 
Departure


*Session Chair †Speaker invited, not yet responded.


Keystone Symposia thanks our Sponsors for generously supporting this meeting:

AstraZeneca Boehringer Ingelheim Pharmaceuticals, Inc.
H3 Biomedicine Inc. Nestlé Institute of Health Sciences
Onyx Pharmaceuticals, Inc. Science for Life Laboratory - Stockholm
Knut and Alice Wallenberg Foundation
 

We gratefully acknowledge additional support for this conference from:


Science Translational Medicine

We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:



Novartis Institutes for BioMedical Research

We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

S. Karger AG - ISCN 2013

Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:


Click here to view more of these organizations

If your organization is interested in joining these entities in support of Keystone Symposia, please contact: Melissa Carrera, Assistant Director of Development, Email: MelissaC@keystonesymposia.org,
Phone:+1 970-262-2679

Click here for more information on Industry Support and Recognition Opportunities.

If you are interested in becoming an advertising/marketing in-kind partner, please contact:
Yvonne Psaila, Director, Marketing and Communications, Email: yvonnep@keystonesymposia.org,
Phone:+1 970-262-2676